Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus

References

• WHO. Hepatitis B. 2013. Available from: www.who.int/mediacentre/factsheets/fs204/en/index.html [Last accessed 7 February] [2014]
   Google Scholar
• WHO. Hepatitis C. 2013. Available from: www.who.int/mediacentre/factsheets/fs164/en/index.html [Last accessed 1 January 2014]
   Google Scholar
• Cacoub P, Terrier B. Hepatitis B-related autoimmune manifestations. Rheum Dis Clin North Am 2009;35(1):125-37
   PubMed Web of Science ®Google Scholar
• Ferri C, Antonelli A, Mascia MT, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007;39(1):S13-21
   PubMedGoogle Scholar
• Takahashi K, Nishida N, Kawabata H, et al. Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection. Intern Med 2012;51(19):2745-7
   PubMed Web of Science ®Google Scholar
• Fusco F, D’Anzeo G, Rossi A, et al. Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature. Expert Opin Pharmacother 2013;14(18):2533-44
   PubMed Web of Science ®Google Scholar
• CoppolaN, Gentile I, Pasquale G, et al. Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. Ann Hepatol 2014;13(1):20-6
   Web of Science ®Google Scholar
• Gentile I, Coppola N, Pasquale G, et al. A simple noninvasive score based on routine parameters can predict liver cirrhosis in patients with chronic Hepatitis C. Hepat Mon 2013;13(5):e8352
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Pisaturo M, Stanzione M, et al. presentation, outcomes, and response to therapy among patients with acute exacerbation of chronic hepatitis C. Clin Gastroenterol Hepatol 2013;13(13):00466-7
   Google Scholar
• Sagnelli E, Santantonio T, Coppola N, et al. Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment. Infection 2014;12:12
   Google Scholar
• Gentile I, Buonomo AR, Zappulo E, Borgia G. Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters? Infez Med 2014;22(1):11-18
   PubMedGoogle Scholar
• Fortunato G, Calcagno G, Bresciamorra V, et al. Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes. J Interferon Cytokine Res 2008;28(3):141-52
   PubMed Web of Science ®Google Scholar
• Fortunato G, Castaldo G, Oriani G, et al. Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin Chem 2001;47(9):1696-700
   PubMed Web of Science ®Google Scholar
• Gentile I, Meola M, Buonomo AR, et al. Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection. In Vivo 2013;27(6):773-7
   PubMed Web of Science ®Google Scholar
• Piazza M. Epatite virale acuta e cronica. 9th edition. Ghedini SAS, Naples, Italy 2009
   Google Scholar
• Coppola N, Loquercio G, Tonziello G, et al. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J Clin Virol 2013;58(1):315-17
   PubMed Web of Science ®Google Scholar
• Coppola N, Tonziello G, Colombatto P, et al. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. J Infect 2013;67(4):322-8
   PubMed Web of Science ®Google Scholar
• Coppola N, Masiello A, Tonziello G, et al. Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. J Viral Hepat 2010;17(7):493-500
   PubMed Web of Science ®Google Scholar
• Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol 2012;18(34):4677-83
   PubMed Web of Science ®Google Scholar
• Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009;1:133-9
   Google Scholar
• Lavanchy D. Chronic viral hepatitis as a public health issue in the world. Best Pract Res Clin Gastroenterol 2008;22(6):991-1008
   PubMed Web of Science ®Google Scholar
• Gentile I, Di Flumeri G, Scarica S, et al. Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy. Minerva Urol Nefrol 2013;65(1):83-4
   PubMed Web of Science ®Google Scholar
• Carney K, Dhalla S, Aytaman A, et al. Association of tattooing and hepatitis C virus infection: a multicenter case-control study. Hepatology 2013;57(6):2117-23
   PubMed Web of Science ®Google Scholar
• Coppola N, Pisapia R, Tonziello G, et al. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. J Clin Virol 2009;46(3):222-9
   PubMed Web of Science ®Google Scholar
• Coppola N, Pisapia R, Marrocco C, et al. Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol 2007;40(2):110-15
   PubMed Web of Science ®Google Scholar
• Gentile I, De Stefano A, Di Flumeri G, et al. Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report. In Vivo 2013;27(4):527-9
   PubMed Web of Science ®Google Scholar
• Davis GL, Alter MJ, El-Serag H, et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010;138(2):513-21
   PubMed Web of Science ®Google Scholar
• Gentile I, Viola C, Graf M, et al. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. J Clin Gastroenterol 2009;43(1):81-7
   PubMed Web of Science ®Google Scholar
• Filippini P, Coppola N, Scolastico C, et al. Does HIV infection favor the sexual transmission of hepatitis C? Sex Transm Dis 2001;28(12):725-9
   PubMed Web of Science ®Google Scholar
• Maasoumy B, Wedemeyer H. Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol 2012;26(4):401-12
   PubMed Web of Science ®Google Scholar
• Cottrell EB, Chou R, Wasson N, et al. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2013;158(2):109-13
   PubMed Web of Science ®Google Scholar
• Borgia G, Gentile I. Treating chronic hepatitis B: today and tomorrow. Curr Med Chem 2006;13(23):2839-55
   PubMed Web of Science ®Google Scholar
• Morisco F, Granata R, Stroffolini T, et al. Sustained virological response: a milestone in the treatment of chronic hepatitis C. World J Gastroenterol 2013;19(18):2793-8
   PubMed Web of Science ®Google Scholar
• Gentile I, Borgia G. Surrogate endpoints and non-inferiority trials in chronic viral hepatitis. J Hepatol 2010;52(5):778
   PubMed Web of Science ®Google Scholar
• Coppola N, Pisaturo M, Tonziello G, et al. Efficacy of Pegylated interferon alpha-2a and alpha-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis. BMC Infect Dis 2012;12(357):1471-2334
   Google Scholar
• Borgia G, Gentile I, Fortunato G, et al. Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. Liver Int 2009;29(2):248-52
   PubMed Web of Science ®Google Scholar
• Gentile I, Viola C, Paesano L, et al. Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial. J Clin Apher 2009;24(5):190-6
   PubMed Web of Science ®Google Scholar
• Abu-Mouch S, Fireman Z, Jarchovsky J, et al. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J Gastroenterol 2011;17(47):5184-90
   PubMed Web of Science ®Google Scholar
• Coppola N, Marrone A, Pisaturo M, et al. Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection. Eur J Clin Microbiol Infect Dis 2014;33(4):559-67
   PubMed Web of Science ®Google Scholar
• Gentile I, Viola C, Borgia F, et al. Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infection. Curr Med Chem 2009;16(9):1115-21
   PubMed Web of Science ®Google Scholar
• Mederacke I, Wedemeyer H, Manns MP. Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection. Curr Opin Investig Drugs 2009;10(2):181-9
   PubMedGoogle Scholar
• Gentile I, Carleo MA, Borgia F, et al. The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. Expert Opin Investig Drugs 2010;19(1):151-9
   PubMed Web of Science ®Google Scholar
• Approval of Sovaldi (sofosbuvir) tablets for the treatment of chronic hepatitis C. FDA. FDA press release; 2013. Available from: www.fda.gov/forconsumers/byaudience/forpatientadvocates/ucm377920.htm [Last accessed 1 January 2014]
   Google Scholar
• EMA. European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C. 2013. Available from: www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/11/WC500155469.pdf [Last accessed 1 February 2014]
   Google Scholar
• Gentile I, Borgia F, Buonomo AR, et al. A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir. Curr Med Chem 2013;20(30):3733-42
   PubMed Web of Science ®Google Scholar
• Gentile I, Borgia F, Zappulo E, et al. Efficacy and safety of sofosbuvir in treatment of chronic hepatitis C: the dawn of the a new era. Rev Recent Clin Trials 2013; Epub ahead of print
   Google Scholar
• Yin Y, Wu L, Zhang J, et al. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. J Infect 2013;66(5):447-52
   PubMed Web of Science ®Google Scholar
• Piratvisuth T. Optimal management of HBV infection during pregnancy. Liver Int 2013;1:188-94
   Google Scholar
• Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastroenterol Clin North Am 2011;40(2):355-72
   PubMed Web of Science ®Google Scholar
• Floreani A. Hepatitis C and pregnancy. World J Gastroenterol 2013;19(40):6714-20
   PubMed Web of Science ®Google Scholar
• Indolfi G, Resti M. Perinatal transmission of hepatitis C virus infection. J Med Virol 2009;81(5):836-43
   PubMed Web of Science ®Google Scholar
• Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005;192(11):1880-9
   PubMed Web of Science ®Google Scholar
• Indolfi G, Azzari C, Resti M. Perinatal transmission of hepatitis C virus. J Pediatr 2013;163(6):1549-52
   PubMed Web of Science ®Google Scholar
• Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis 2007;44(8):1123-31
   PubMed Web of Science ®Google Scholar
• European Paediatric Hepatitis C Virus Network. A significant sex--but not elective cesarean section--effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005;192(11):1872-9
   PubMed Web of Science ®Google Scholar
• Prasad MR, Honegger JR. Hepatitis C virus in pregnancy. Am J Perinatol 2013;30(2):149-59
   PubMed Web of Science ®Google Scholar
• Kumar A. Hepatitis B virus infection and pregnancy: a practical approach. Indian J Gastroenterol 2012;31(2):43-54
   PubMedGoogle Scholar
• Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009;190(9):489-92
   PubMed Web of Science ®Google Scholar
• Bzowej NH. Optimal management of the hepatitis B patient who desires pregnancy or is pregnant. Curr Hepat Rep 2012;11(2):82-9
   PubMedGoogle Scholar
• Wen WH, Chang MH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013;59(1):24-30
   PubMed Web of Science ®Google Scholar
• Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012;19(2):1365-2893
   Web of Science ®Google Scholar
• The Antiretroviral Pregnancy Registry. Pregnancy A, Registry. 2013. Available from: www.apregistry.com/forms/interim_report.pdf
   Google Scholar
• Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009;16(2):94-103
   PubMed Web of Science ®Google Scholar
• Ayres A, Yuen L, Jackson KM, et al. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations. J Viral Hepat 2013;11(10):12212
   Google Scholar
• Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011;55(6):1215-21
   PubMed Web of Science ®Google Scholar
• Deng M, Zhou X, Gao S, et al. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis. Virol J 2012;9(185):9-185
   PubMedGoogle Scholar
• Pan CQ, Mi LJ, Bunchorntavakul C, et al. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Dig Dis Sci 2012;57(9):2423-9
   PubMed Web of Science ®Google Scholar
• Celen MK, Mert D, Ay M, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol 2013;19(48):9377-82
   PubMed Web of Science ®Google Scholar
• Nardiello S, Orsini A, Gentile I, Gaeta GB. [HBV and pregnancy]. Infez Med 2011;19(3):139-45
   PubMedGoogle Scholar
• Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 2010;14(7):27
   Web of Science ®Google Scholar
• Xu H, Zeng T, Liu JY, et al. Measures to Reduce Mother-to-Child Transmission of Hepatitis B Virus in China: a Meta-Analysis. Dig Dis Sci 2013;6:6
   Google Scholar
• Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J 2002;115(10):1510-12
   PubMed Web of Science ®Google Scholar
• Yang J, Zeng XM, Men YL, Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus – a systematic review. Virol J 2008;5(100):5-100
   PubMedGoogle Scholar
• Hu Y, Chen J, Wen J, et al. Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus. BMC Pregnancy Childbirth 2013;13(1):119
   PubMedGoogle Scholar
• Han GR, Xu CL, Zhao W, Yang YF. Management of chronic hepatitis B in pregnancy. World J Gastroenterol 2012;18(33):4517-21
   PubMed Web of Science ®Google Scholar
• Tran TT. Management of hepatitis B in pregnancy: weighing the options. Cleve Clin J Med 2009;76(3):06
   PubMedGoogle Scholar
• Mok J, Pembrey L, Tovo PA, Newell ML. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 2005;90(2):F156-60
   PubMed Web of Science ®Google Scholar
• Yazdani Brojeni P, Matok I, Garcia Bournissen F, Koren G. A systematic review of the fetal safety of interferon alpha. Reprod Toxicol 2012;33(3):265-8
   PubMed Web of Science ®Google Scholar
• Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment? J Viral Hepat 2011;18(4):229-36
   PubMed Web of Science ®Google Scholar
• Lange CM, Zeuzem S. Perspectives and challenges of interferon-free therapy for chronic hepatitis C. J Hepatol 2013;58(3):583-92
   PubMed Web of Science ®Google Scholar
• Gentile I, Buonomo AR, Borgia F, et al. Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. Expert Opin Investig Drugs 2014;23(4):561-71
   PubMed Web of Science ®Google Scholar
• Gentile I, Borgia F, Coppola N, et al. Daclatasvir: the First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A. Curr Med Chem 2014;21(12):1391-404
   PubMed Web of Science ®Google Scholar
• Gentile I, Buonomo AR, Borgia F, et al. MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection. Expert Opin Investig Drugs 2014;23(5):719-28
   PubMed Web of Science ®Google Scholar
• Gibb DM, Goodall RL, Dunn DT, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000;356(9233):904-7
   PubMed Web of Science ®Google Scholar
• Delotte J, Barjoan EM, Berrebi A, et al. Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study. J Matern Fetal Neonatal Med 2013;23:23
   Google Scholar
• Ghamar Chehreh ME, Tabatabaei SV, Khazanehdari S, Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Arch Gynecol Obstet 2011;283(2):255-60
   PubMed Web of Science ®Google Scholar
• McIntyre PG, Tosh K, McGuire W. Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database Syst Rev 2006(4):CD005546
   PubMed Web of Science ®Google Scholar
• Spada E, Tosti ME, Zuccaro O, et al. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect 2011;62(2):165-71
   PubMed Web of Science ®Google Scholar
• Ruiz-Extremera A, Munoz-Gamez JA, Salmeron-Ruiz MA, et al. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology 2011;53(6):1830-8
   PubMed Web of Science ®Google Scholar
• Farmand S, Wirth S, Loffler H, et al. Spontaneous clearance of hepatitis C virus in vertically infected children. Eur J Pediatr 2012;171(2):253-8
   PubMed Web of Science ®Google Scholar
• Indolfi G, Bartolini E, Resti M. Spontaneous clearance of hepatitis C virus in vertically infected children: any clue for treatment? Eur J Pediatr 2011;170(12):1621
   PubMed Web of Science ®Google Scholar
• Indolfi G, Mangone G, Bartolini E, et al. Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 Genomes Project data. PLoS One 2014;9(1):e85899
   PubMed Web of Science ®Google Scholar